Economists and lawmakers say the president’s claims of a manufacturing boom are more like a bust. Alex Woodward reports ...

Q4 2025 Earnings Call March 12, 2026 8:00 AM EDTCompany ParticipantsAnne Ji - Senior Director of Investor RelationsHuazhi Hu ...

Economists and lawmakers say the president’s claims of a manufacturing boom are more like a bust. Alex Woodward reports ...

Despite claims of defending U.S. exporters, the data could justify import tariffs, raise costs for American manufacturers and consumers, and lead to domestic carbon pricing, clashing with Trump ...

The military conflict in Iran and the Middle East is curtailing the global flow of oil and natural gas. Along with ...

Every time we get a press release from the governor’s office like the one we got today about Fukoku Korea investing $18.9 ...

Bill Cooper stated, "We expect a sequential decline in non-product revenue due to a project completion in Q4 2025, which will ...

biote Corp. (NASDAQ:BTMD) Q4 2025 Earnings Call Transcript March 11, 2026 biote Corp. beats earnings expectations. Reported EPS is $0.06339, expectations were $0.04. Operator: Good day, and welcome to ...

NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Sales of $48.5 ...

Codexis, Inc. (NASDAQ:CDXS) Q4 2025 Earnings Call Transcript March 11, 2026 Codexis, Inc. beats earnings expectations. Reported EPS is $0.1056, expectations were $-0.03. Operator: Greetings. Welcome ...

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.

Procedure Revenue -- $31.8 million, reflecting a 13% decline primarily linked to higher clinic attrition and lower procedure volumes. Dietary Supplement Revenue -- Grew 16% to $11.7 million, driven ...